Since COVID-19 reared its ugly head more than 18 months ago, public health experts have longed to bolster their pandemic toolbox with a pill that could easily treat coronavirus. They may finally have one. Fluvoxamine, an off-patent, widely available antidepressant,...
As the US prepares to enter into its third winter season dealing with COVID-19, an unanswered question—first asked back in the earliest days of the pandemic—remains: When will it be over? Unfortunately, the answer may be “never”—many experts no longer...
To try to gauge where things stand, the reporter asked a number of infectious diseases experts — public health experts, epidemiologists, immunologists, and virologists — about the risks they are willing to take now, figuring that their answers might give...
Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers. The study, which was published this week...
As you read this, a worker in a tropical rainforest is clearing brush in preparation for a commercial agricultural operation. He’s far from the markets of home, and so he takes his food as he finds it, likely killing a bird or small mammal—a monkey, say, or a bat—to...
